3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Down Syndrome
2
Blast Crisis
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
6
pembrolizumab
5
fludarabine phosphate
5
Vinblastine
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
fludarabine
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
pegfilgrastim
3
Etoposide
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Azacitidine
2
treosulfan
1
tocilizumab
1
thymoglobulin
1
tafasitamab
1
selinexor
1
polatuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
merphos
×
30 days
×
Clear all
No trials found.